D-0871-2016 Class I Terminated

Recalled by Pharmakon Pharmaceuticals — Noblesville, IN

FDA drug recall D-0871-2016 was initiated by Pharmakon Pharmaceuticals on Feb 11, 2016 and is designated Class I. Reason for recall: Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj. The recall status is terminated (terminated May 16, 2017). Affected quantity: 75 Syringes.

Recall Details

Product Type
Drugs
Report Date
Jun 1, 2016
Initiation Date
Feb 11, 2016
Termination Date
May 16, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
75 Syringes

Product Description

Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1 mL, This is a compounded drug, CII, IV Use, syringe, Pharmakon Pharmaceuticals, NDC 45183-0322-78.

Reason for Recall

Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.

Distribution Pattern

IN and IL

Code Information

Lot #: E52418EV11C, Exp 03/19/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0871-2016
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.